Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.
Currently, there are no FDA-licensed vaccines or therapeutics for eastern equine encephalitis virus (EEEV) for human use. We recently developed several methods to inactivate CVEV1219, a chimeric live-attenuated eastern equine encephalitis virus (EEEV). Dosage and schedule studies were conducted to e...
Main Authors: | Shelley P Honnold, Russell R Bakken, Diana Fisher, Cathleen M Lind, Jeffrey W Cohen, Lori T Eccleston, Kevin B Spurgers, Radha K Maheshwari, Pamela J Glass |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4130539?pdf=render |
Similar Items
-
MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques
by: Brandon J. Beddingfield, et al.
Published: (2024-02-01) -
Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods
by: Mahgol Behnia, et al.
Published: (2022-01-01) -
Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs
by: Norris Sarah, et al.
Published: (2009-10-01) -
Detection of Venezuelan Equine Encephalitis Virus from Brain Samples of Equines with Encephalitis
by: Bernal León, et al.
Published: (2023-08-01) -
Defining the Cynomolgus Macaque (<i>Macaca fascicularis</i>) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype
by: Crystal W. Burke, et al.
Published: (2023-11-01)